Clinical utility of interleukin-28B testing in patients with genotype 1

Hepatology. 2012 Jul;56(1):367-72. doi: 10.1002/hep.25793.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Confidence Intervals
  • Ethnicity / genetics
  • Female
  • Genotype
  • Hepacivirus / drug effects
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / ethnology
  • Hepatitis C, Chronic / genetics*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Interferons
  • Interleukins / genetics*
  • Male
  • Odds Ratio
  • Polyethylene Glycols / therapeutic use
  • Polymorphism, Single Nucleotide
  • Predictive Value of Tests
  • Prognosis
  • Recombinant Proteins / therapeutic use
  • Ribavirin / therapeutic use
  • Risk Factors
  • Treatment Outcome
  • Viral Load / drug effects*
  • Viral Load / genetics

Substances

  • Antiviral Agents
  • interferon-lambda, human
  • Interferon alpha-2
  • Interferon-alpha
  • Interleukins
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • Interferons
  • peginterferon alfa-2b